Pretargeted Radioimmunotherapy in Rapidly Progressing, Metastatic, Medullary Thyroid Cancer.

A conference paper about the methods to be used in investigating the mortality of medullary thyroid cancer (MTC) patients with restricted residual disease and/or distant metastases is presented. It discusses the administration calcitonin doubling on the early distinction of the treatment of high-risk and low-risk patients. It investigates the use of magnetic resonance imaging (MRI) in finding liver metastases from endocrine tumors among patients and the distribution of MTC to bone marrow.